The Isaias Group controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile4 entries
2017
Fetal-tissue allegations involving associated biotechnology companies
California prosecutors alleged that Da Vinci Biosciences and DV Biologics, companies linked to the wider Isaías business network, unlawfully sold fetal tissue and cells. The companies settled for $7.785 million and agreed to stop operating in California.
2016
UN finding concerning Constituent Mandate 13
The UN Human Rights Committee found that Ecuador's Constituent Mandate 13 violated the Isaías brothers' due-process rights by restricting access to legal remedies concerning the seized assets.
2008
Seizure of media and business assets
The Correa administration seized or took control of companies associated with the group. The Isaías family and its supporters characterized the action as politically motivated, while the government presented it as a recovery measure linked to alleged banking losses.
1998
Filanbanco and the Ecuadorian financial crisis
During Ecuador's 1998–1999 banking crisis, the government focused substantial blame on Filanbanco and the Isaías brothers after numerous banks became insolvent. The state takeover of Filanbanco and subsequent asset seizures became the central political and legal controversy surrounding the group.